South Korea Invites Bio-Health Firms for 2026 ‘Innovation Premier 1000’ Program

The South Korean Ministry of Health and Welfare (MOHW) has announced a nationwide call for applications for its 2026 ‘Innovation Premier 1000’ program, specifically targeting the rapidly evolving bio-health sector. This initiative seeks to identify and support highly innovative small and medium-sized enterprises (SMEs) and mid-sized companies, aiming to accelerate their growth and bolster their global competitiveness.

Launched annually, the ‘Innovation Premier 1000’ program is a key government strategy designed to foster companies with significant innovation potential. For the bio-health sector, this includes firms involved in pharmaceuticals, medical devices, biotechnology, and digital healthcare. The program aims to provide selected companies with resources and support necessary to scale up their operations and make a mark on the international stage.

Eligibility for the program is open to innovative SMEs and mid-sized companies currently operating within South Korea’s bio-health industry. Interested firms can apply starting from April 3, 2026. The application window will remain open until December 31, 2026, giving prospective participants ample time to prepare their submissions.

Prospective applicants are strongly encouraged to consult the official announcement and accompanying detailed guidelines (which typically include application forms and specific criteria) issued by the Ministry of Health and Welfare. These documents provide comprehensive information on the application process, selection criteria, and the scope of support offered. Further details can be found on the MOHW’s official website.

This program underscores South Korea’s commitment to becoming a global leader in bio-health, identifying the sector as a critical future growth engine. By nurturing innovative domestic companies, the government aims to enhance the nation’s scientific and technological prowess while creating new economic opportunities.

Source: 보건복지부 — Original Article (Korean)